SOURCE: Industrial Info Resources

Industrial Info Resources

August 20, 2014 06:15 ET

North American Pharma-Biotech Sector to Wrap Up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Aug 20, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Midway through the third quarter of 2014, the Pharmaceutical-Biotech Industry is busy finishing an impressive array of capital construction projects. The sector is on target to complete construction on a total of 156 North American capital projects. A recent survey of reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that the projects represent a total investment value (TIV) of $1.3 billion.

Within this article: Details on projects from companies such as Genzyme, GlaxoSmithKline (NYSE:GSK), Ipsen Biosciences and Biomed Realty Trust.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch